D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate FDMT stock a Buy.

AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...

The AAV Innovation Summit 2025, hosted by Form Bio, will bring together top experts in gene therapy to discuss the latest ...

Despite its promise, the integration of AI in coral reef conservation faces several challenges. Data availability and quality ...

Science-based lessons for improving the art of effective self-presentation and increasing your likelihood of getting a job ...

Ransomware attacks remain a significant threat to organizations worldwide, with cybercriminals continuously evolving tactics.

As NASA plans to establish a permanent Moon base via its Artemis program, it is looking to avoid the dangers of lunar ...

Adobe is also offering two new subscription plans for users to access new capabilities via the Firefly web app.

AI-driven models for predicting concrete compressive strength show promise, with machine learning techniques improving accuracy in SCM formulations.

Leishmaniasis is a life-threatening parasitic infection and one of the most concerning neglected vector-borne tropical diseases worldwide. Current leishmaniasis chemotherapeuticals are poorly ...

GridGain, provider of a leading real-time data processing and analytics platform, is introducing GridGain for AI, enabling organizations to use GridGain as a low-latency data store for real-time AI ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.